EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Australasia

Kazia to use drug with radiotherapy for brain cancer treatment

GDC-0084 is a PI3K inhibitor that can cross the blood-brain barrier, and as such it may be able to reduce the problem of resistance to radiotherapy Kazia Therapeut...
Continue Reading →
Asia Pacific

FIND, ILBS calls for joint action against hepatitis

The “Delhi Model” is a comprehensive guide highlighting best practices adopted to address hepatitis C elimination through the HEAD-Start project (Hepatitis C Elimina...
Continue Reading →
news

Laurus Labs launches Pregabalin Capsules in US market

Pregabalin Capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy Laurus Labs Limited, a Hyderabad based research...
Continue Reading →
Asia Pacific

Akebia submits new application for anemia drug in Japan

JNDA Submission represents first regulatory submission for marketing approval of vadadustat Akebia Therapeutics, Inc.  has announced that Mitsubishi Tanabe Ph...
Continue Reading →
Asia Pacific

FDA approves arthritis drug by Samsung Bioepis

Samsung Bioepis secures third FDA approval in the past seven months Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing ...
Continue Reading →
Asia Pacific

Sanofi signs exclusive deal for OTC rights to Tamiflu

Sanofi will be responsible for leading the clinical program and funding all studies needed to support the OTC switch in the US in consultation with leading experts i...
Continue Reading →
Asia Pacific

Trivitron Healthcare launches fully automated clinical chemistry analyzer

Affordable and Accessible Diagnostic solutions for today and tomorrow Trivitron Healthcare, the ace Indian health technology organization, takes another leap in pr...
Continue Reading →
Europe

UK First as London Hospital Takes Part in New International Clinical Trial for Brain Cancer

Consultant oncologists and neurologists are being asked to put patients forward to participate in a landmark international clinical trial of a new radiation treatmen...
Continue Reading →
Europe

Despite late-stage win, investors not sold on Global Blood sickle cell drug

Global Blood Therapeutics has in hand positive data from a late-stage study of its sickle cell disease drug, which could be a "promising advancement" in the way t...
Continue Reading →
news

Bowel cancer: 3-drug combo may offer alternative to chemo

Chemotherapy treatment for people who have advanced bowel cancer and a particular genetic mutation is commonly ineffective. A combination of three different drugs co...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18